Quarterly report pursuant to Section 13 or 15(d)

EQUITY TRANSACTIONS IN THE NINE MONTHS ENDED DECEMBER 31, 2022 (Details Narrative)

v3.22.4
EQUITY TRANSACTIONS IN THE NINE MONTHS ENDED DECEMBER 31, 2022 (Details Narrative)
9 Months Ended
Dec. 31, 2022
USD ($)
shares
Restricted Stock Units (RSUs) [Member]  
Securities Financing Transaction [Line Items]  
Number of shares authorized 1,800,000
Eligible Directors Each [Member] | Restricted Stock Units (RSUs) [Member]  
Securities Financing Transaction [Line Items]  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period 34,247
Newly Appointed Director [Member] | Restricted Stock Units (RSUs) [Member]  
Securities Financing Transaction [Line Items]  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period 51,370
Offering Agreement [Member]  
Securities Financing Transaction [Line Items]  
Proceeds from issuance of equity | $ $ 8,927,211
Stock issued new, shares issued 7,480,836
Offering Agreement [Member] | Other Offering Expense [Member]  
Securities Financing Transaction [Line Items]  
Payment of stock issuance costs | $ $ 27,153
Offering Agreement [Member] | Hc Wainwright [Member]  
Securities Financing Transaction [Line Items]  
Payment of commissions | $ $ 229,610